Published 5 days ago • loading... • Updated 5 days ago

DC judge rejects Merck’s IRA case more than three years after it was filed

After lengthy consideration, a DC federal judge on Monday rejected Merck’s challenge to Medicare drug price negotiations. Judge Colleen Kollar-Kotelly of the US District Court for the District of Columbia

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

endpoints.news

DC judge rejects Merck’s IRA case more than three years after it was filed

5 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated5 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news 5 days ago on Monday, August 24, 2026.

Sources are mostly out of (0)

DC judge rejects Merck’s IRA case more than three years after it was filed

1 Articles

1 Articles

DC judge rejects Merck’s IRA case more than three years after it was filed

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

A New Era in Drug Pricing

Drug Prices Will Change Every Week - Sözcü Newspaper

Do mRNA Tumour Vaccines Herald a New Revolution in Cancer Treatment?

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

Pancreatic Cancer Vaccine Shows New Promise as Researchers Seek a Way to Outsmart One of the Deadliest Cancers - FINCHANNEL

CMS Says It Has Blocked or Recovered More Than $1.6 Billion in Suspect Medicare Lab Payments

Similar News Topics

Similar News Topics

More stories like this

A New Era in Drug Pricing

Drug Prices Will Change Every Week - Sözcü Newspaper

Do mRNA Tumour Vaccines Herald a New Revolution in Cancer Treatment?

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

Pancreatic Cancer Vaccine Shows New Promise as Researchers Seek a Way to Outsmart One of the Deadliest Cancers - FINCHANNEL

CMS Says It Has Blocked or Recovered More Than $1.6 Billion in Suspect Medicare Lab Payments

DC judge rejects Merck’s IRA case more than three years after it was filed

1 Articles

1 Articles

DC judge rejects Merck’s IRA case more than three years after it was filed

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

A New Era in Drug Pricing

Drug Prices Will Change Every Week - Sözcü Newspaper

Do mRNA Tumour Vaccines Herald a New Revolution in Cancer Treatment?

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

Pancreatic Cancer Vaccine Shows New Promise as Researchers Seek a Way to Outsmart One of the Deadliest Cancers - FINCHANNEL

CMS Says It Has Blocked or Recovered More Than $1.6 Billion in Suspect Medicare Lab Payments

Similar News Topics

Similar News Topics

More stories like this

A New Era in Drug Pricing

Drug Prices Will Change Every Week - Sözcü Newspaper

Do mRNA Tumour Vaccines Herald a New Revolution in Cancer Treatment?

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

Pancreatic Cancer Vaccine Shows New Promise as Researchers Seek a Way to Outsmart One of the Deadliest Cancers - FINCHANNEL

CMS Says It Has Blocked or Recovered More Than $1.6 Billion in Suspect Medicare Lab Payments

Bias Distribution

Factuality